Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-000706

Chief Financial Officer bought 66,666 shares at $0.30 ($20,000)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-01 Purchase : show line 1 in the form +66,666 $0.30 $20,000 103,438 D
Open-market purchases · 66,666 sh · avg $0.30 · $20,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-01 Grant or award : show line 2 in the form Series A Warrant to purchase common stock +66,666 94,906 D
2024-02-01 Grant or award : show line 3 in the form Series B Warrant to purchase common stock +66,666 161,572 D
Loading xslF345X05/ownership.xml…